@ShahidNShah
For several years now, individual sectors within the U.S. health care industry have grown increasingly nuanced. Provider organizations and payers have been faced with a number of challenges over recent years, which are expected to carry over into 2025. Pharmacy services have been particularly unique, with some organizations reaping the benefits of pharmaceutical innovation and novel delivery models and some battling increased regulatory scrutiny. The health care services and technology (HST) sector has enjoyed the continued demand for data, analytics and software of the 2020s.
Pharmacy services face margin and pricing challenges, but growth opportunities in biosimilars, specialty drugs, and integrated care models—combined with strategic technology use across providers, payers, and tech firms—can support sustainable improvement for the broader health system.
Continue reading at medicaleconomics.com
For the third consecutive year, global medical costs are expected to rise by double-digit percentages, with no significant relief in sight, according to the 2025 Global Medical Trends Survey conducted …
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 18, 2025 at 4:23am